EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.
about
Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic targetNational Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent NeoplasmsEpstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature ReviewCognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationMemory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation eventAlterations in Memory and Impact on Academic Outcomes in Children Following Allogeneic Hematopoietic Cell Transplantation.Immunotherapy for viral and fungal infections.The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells.Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma.Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.Successful treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disease with central nervous system involvement following allogeneic haematopoietic stem cell transplantation - a case study.Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients.EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting.TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.Epstein-Barr Virus+ Smooth Muscle Tumors as Manifestation of Primary Immunodeficiency Disorders.
P2860
Q26822550-2AF61CD2-C43E-4139-8464-752378B4AD9DQ29248394-D40799D2-6F64-4ACA-814B-CE367C9FCFB3Q33619215-205FA500-83F5-40C5-AC78-BBE99970F5B3Q34991001-F62B3387-B122-433D-AD2A-883FB47438F7Q36519976-32774E1A-8C8B-4547-AA39-3A5DB80C4447Q38384715-A8357021-B8C4-4101-A02F-23FF0F1AB177Q38514499-DCE931AC-543C-4C3B-9D7F-049DA594B494Q38956462-195F5761-365E-48A0-BA1C-0681B3215702Q39036600-8851169A-F63F-4559-BB64-80E7F8694CB7Q40106713-7745F0D8-A5C0-47DA-809C-115B429998EEQ40519555-FE5AF96C-6EA4-4DEA-99B7-7697C7EEB6C5Q41602911-81BA722D-2C8D-46AB-BB13-FCDC135C9E0AQ41623045-7C22515B-3407-4B1D-BFE8-D3B0EE441BC7Q42051829-CE5FCC72-8B3E-4B61-ABE1-5C2CC3B8876FQ45347053-7A684477-42B5-4371-96E3-BF76F7832257Q52691571-2A799BF3-3BC6-4EBF-A229-26FF7D06206EQ54256451-51854342-8541-48F0-B45D-E5D50B43E6E6
P2860
EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
EBV-induced post transplant ly ...... n allogeneic hematopoetic SCT.
@en
type
label
EBV-induced post transplant ly ...... n allogeneic hematopoetic SCT.
@en
prefLabel
EBV-induced post transplant ly ...... n allogeneic hematopoetic SCT.
@en
P2093
P2860
P356
P1476
EBV-induced post transplant ly ...... in allogeneic hematopoetic SCT
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2013.96
P407
P577
2013-07-08T00:00:00Z
P5875
P6179
1027644592